{
  "legislationId": "119_S_4106",
  "lastUpdate": "2026-03-26T12:37:11.354Z",
  "history": [
    {
      "timestamp": "2026-03-26T12:37:11.354Z",
      "source_url": "https://www.congress.gov/119/bills/s4106/BILLS-119s4106is.htm",
      "model": "gemini-3.1-pro-preview",
      "prompt_sent": "\nJesteś LEGISLATIVE SURGEON.\nTwoim zadaniem jest audyt i naprawa streszczenia (JSON) pod kątem zgodności z tekstem źródłowym (SOURCE).\nZASADA FUNDAMENTALNA: \"NO NEW INFORMATION\" (żadnych nowych informacji).\nStreszczenie może jedynie transformować informacje zawarte w SOURCE (skracać, tłumaczyć, sumować). Nie może generować nowych informacji, których nie ma w SOURCE.\n\nPROCEDURA WERYFIKACJI (wykonaj dla każdego zdania w JSON):\nZadaj sobie pytanie: \"Czy potrafię wskazać w SOURCE konkretny fragment, który potwierdza to stwierdzenie?\"\nJEŚLI ODPOWIEDŹ BRZMI \"TAK\":\nInformacja jest potwierdzona cytatem, synonimem lub wynikiem matematycznym z danych w tekście.\nDECYZJA: Zostaw bez zmian.\nJEŚLI ODPOWIEDŹ BRZMI \"NIE\":\nInformacji nie ma w tekście (jest to halucynacja, zewnętrzna wiedza modelu, nadinterpretacja lub niepotrzebna ekstrapolacja).\nDECYZJA: Usuń tę informację lub zmień ją tak, aby miała pokrycie w tekście.\nJEŚLI ODPOWIEDŹ BRZMI \"TO ZALEŻY\":\nTekst jest niejasny, a streszczenie \"zgaduje\" (np. podając konkretny przykład dla ogólnego terminu).\nDECYZJA: Bądź bezpieczny. Usuń zgadywanie. Użyj terminologii z tekstu.\n\nKATEGORIE RYZYKA (szczególna uwaga):\nDaty (start obowiązywania vs start finansowania).\nLiczby (konkretne kwoty muszą wynikać z tekstu).\nPodmioty (kto co robi).\nZakres (co ustawa obejmuje, a czego nie).\n\nINPUT:\n--- SOURCE_TEXT START ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 4106 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 4106 To amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES March 17, 2026 Mr. Cotton (for himself and Mr. Kaine) introduced the following bill; which was read twice and referred to the Committee on the Judiciary _______________________________________________________________________ A BILL To amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Rx Access, Choice, Cost Equity, and Supply Stability Act'' or the ``Rx ACCESS Act''. SEC. 2. IMPROVEMENTS RELATING TO ACCESS, FAIRNESS, AND TRANSPARENCY UNDER TRICARE PHARMACY BENEFITS PROGRAM. (a) Beneficiary Election of Prescription Refill Means.--Section 1074g(a)(9) of title 10, United States Code, is amended-- (1) in subparagraph (A), by inserting ``, and ending on October 1, 2026'' after ``Beginning on October 1, 2015''; and (2) by adding at the end the following new subparagraph: ``(D) Beginning on October 1, 2026, an eligible covered beneficiary may elect to receive non-generic prescription maintenance medications through any means described in paragraph (2)(E).''. (b) Pharmacy Benefit Manager Reimbursement Standards; Independent Audits.--Section 1074g of title 10, United States Code, as amended by subsection (a), is further amended-- (1) by redesignating subsections (i) and (j) as subsections (j) and (k), respectively; and (2) by inserting after subsection (h) the following new subsection: ``(i) Pharmacy Benefit Manager Reimbursement Standards.--(1) The Secretary of Defense shall ensure that, as a condition of any contract entered into for the administration of the pharmacy benefits program, reimbursement to a retail pharmacy described in subsection (a)(2)(E)(ii) for a pharmaceutical agent provided under such program shall be an amount that is equal to not less than the sum of-- ``(A) either-- ``(i) the actual cost to the pharmacy of acquiring such pharmaceutical agent from a wholesaler, or ``(ii) in the case of a pharmaceutical agent included on the national average drug acquisition cost index published by the Administrator of the Centers for Medicare & Medicaid Services, a proxy amount calculated at a rate that is not lower than the national average acquisition cost for such pharmaceutical agent, as identified on such cost index as of the date of the adjudication of the claim for such reimbursement, and ``(B) a professional dispensing fee that is equal to the professional dispensing fee paid by the State in which the pharmacy is located under title XIX of the Social Security Act (42 U.S.C. 1396 et seq.) for dispensing a prescription drug. ``(2) The contractor administering the pharmacy benefits program may not impose any fees on a retail pharmacy described in subsection (a)(2)(E)(ii), including point-of-sale fees, retroactive fees, or other indirect or hidden fees. ``(3)(A) Not less frequently than annually, the Comptroller General of the United States shall-- ``(i) conduct an audit of-- ``(I) data reported by the contractor responsible for the administration of the pharmacy benefits program relating to the rates of reimbursement under paragraph (1) and any price concessions; and ``(II) the adequacy of the retail pharmacy network under the TRICARE program and access by eligible covered beneficiaries to such network, including with respect to continuity of care, geographic accessibility (taking into account factors in addition to travel time to and from a pharmacy, with special consideration for rural and underserved areas), and the extent to which elections by such beneficiaries under subsection (a)(9) reflect personal preference; and ``(ii) submit the results of such audit to the Committee on Armed Services of the Senate and the Committee on Armed Services of the House of Representatives. ``(B) The Secretary shall ensure that, as a condition of any contract entered into for the administration of the pharmacy benefits program, the contractor provides the Comptroller General information required to conduct the audit under subparagraph (A).''. (c) Report.--Not later than 90 days after the date of the enactment of this Act, the Secretary of Defense shall submit to the congressional defense committees (as defined in section 101(a)(16) of title 10, United States Code) a plan for the implementation of this section. <all>\n--- SOURCE_TEXT END ---\n\n--- FLAGGED_JSON START ---\n{\n  \"pl_ai_title\": \"Leki w programie TRICARE: większy wybór aptek i ochrona przed ukrytymi kosztami\",\n  \"pl_summary\": \"Ustawa daje osobom korzystającym z programu TRICARE większą swobodę w wyborze miejsca zakupu leków markowych. Wprowadza również zasady uczciwego opłacania lokalnych aptek, co ma zapobiec ich zamykaniu i poprawić dostęp do leków, zwłaszcza na wsiach.\",\n  \"pl_key_points\": [\n    \"Pacjenci mogą wybrać realizację recept na leki markowe w dowolnej aptece stacjonarnej zamiast tylko wysyłkowej.\",\n    \"Apteki otrzymają zwrot kosztów pokrywający realną cenę leku oraz standardową opłatę za jego wydanie.\",\n    \"Zakaz nakładania na apteki ukrytych, wstecznych lub dodatkowych opłat przez pośredników.\",\n    \"Coroczne kontrole dostępności aptek dla pacjentów, ze szczególnym uwzględnieniem obszarów wiejskich.\"\n  ],\n  \"eng_ai_title\": \"TRICARE Medications: Greater Pharmacy Choice and Protection from Hidden Costs\",\n  \"eng_summary\": \"This act gives TRICARE beneficiaries more freedom to choose where they purchase brand-name medications. It also establishes fair payment rules for local pharmacies to prevent closures and improve access to medicine, especially in rural areas.\",\n  \"eng_key_points\": [\n    \"Beneficiaries can choose to fill brand-name maintenance prescriptions at retail pharmacies instead of mail-order only.\",\n    \"Pharmacies must be reimbursed based on the actual cost of the drug plus a professional dispensing fee.\",\n    \"Middlemen are prohibited from charging pharmacies hidden, retroactive, or point-of-sale fees.\",\n    \"Mandatory annual audits will check if pharmacy networks are adequate and accessible in underserved areas.\"\n  ],\n  \"de_ai_title\": \"TRICARE-Medikamente: Mehr Apothekenwahl und Schutz vor versteckten Kosten\",\n  \"de_summary\": \"Dieses Gesetz gibt TRICARE-Versicherten mehr Freiheit bei der Wahl ihrer Apotheke für Markenmedikamente. Es führt faire Vergütungsregeln für lokale Apotheken ein, um deren Schließung zu verhindern und die Versorgung in ländlichen Gebieten zu sichern.\",\n  \"de_key_points\": [\n    \"Versicherte können Markenmedikamente in lokalen Apotheken statt nur per Versandhandel beziehen.\",\n    \"Apotheken erhalten eine Erstattung, die den tatsächlichen Einkaufspreis und eine feste Abgabengebühr abdeckt.\",\n    \"Verbot von versteckten oder nachträglichen Gebühren, die Zwischenhändler den Apotheken berechnen.\",\n    \"Jährliche Überprüfung der Erreichbarkeit von Apotheken, insbesondere in ländlichen und unterversorgten Regionen.\"\n  ],\n  \"fr_ai_title\": \"Médicaments TRICARE : plus de choix de pharmacies et protection contre les frais cachés\",\n  \"fr_summary\": \"Cette loi offre aux bénéficiaires de TRICARE une plus grande liberté pour choisir où acheter leurs médicaments de marque. Elle instaure des règles de paiement équitables pour les pharmacies locales afin d'améliorer l'accès aux soins, surtout en zone rurale.\",\n  \"fr_key_points\": [\n    \"Les patients peuvent choisir de retirer leurs médicaments de marque en pharmacie physique plutôt que par correspondance.\",\n    \"Les pharmacies seront remboursées sur la base du coût réel du médicament plus des frais de service standard.\",\n    \"Interdiction des frais cachés ou rétroactifs imposés aux pharmacies par les intermédiaires.\",\n    \"Audits annuels obligatoires pour garantir l'accessibilité des pharmacies dans les zones mal desservies.\"\n  ],\n  \"es_ai_title\": \"Medicamentos TRICARE: más opciones de farmacia y protección contra cargos ocultos\",\n  \"es_summary\": \"Esta ley otorga a los beneficiarios de TRICARE más libertad para elegir dónde comprar sus medicamentos de marca. Establece reglas de pago justo para las farmacias locales para evitar cierres y mejorar el acceso en zonas rurales.\",\n  \"es_key_points\": [\n    \"Los beneficiarios pueden elegir farmacias locales para sus medicamentos de marca en lugar de solo el envío por correo.\",\n    \"Las farmacias recibirán un reembolso que cubra el costo real del medicamento más una tarifa de despacho profesional.\",\n    \"Se prohíbe a los intermediarios imponer tarifas ocultas o retroactivas a las farmacias.\",\n    \"Auditorías anuales para verificar que el acceso a las farmacias sea suficiente en áreas rurales y desatendidas.\"\n  ],\n  \"it_ai_title\": \"Farmaci TRICARE: più scelta della farmacia e stop ai costi nascosti\",\n  \"it_summary\": \"Questa legge offre ai beneficiari TRICARE maggiore libertà nella scelta di dove acquistare i farmaci di marca. Introduce regole per rimborsi equi alle farmacie locali, proteggendo l'accesso ai medicinali soprattutto nelle zone rurali.\",\n  \"it_key_points\": [\n    \"I pazienti possono scegliere la farmacia fisica per i farmaci di marca invece dell'obbligo di spedizione a domicilio.\",\n    \"Le farmacie devono essere rimborsate in base al costo effettivo del farmaco più una tariffa professionale.\",\n    \"Divieto di commissioni nascoste o retroattive applicate dagli intermediari alle farmacie.\",\n    \"Controlli annuali sulla rete delle farmacie per garantire la copertura nelle zone meno servite.\"\n  ],\n  \"nl_ai_title\": \"TRICARE-medicijnen: meer apotheekkeuze en bescherming tegen verborgen kosten\",\n  \"nl_summary\": \"Deze wet geeft TRICARE-verzekerden meer vrijheid om te kiezen waar ze hun merkgeneesmiddelen kopen. Het voert eerlijke betalingsregels in voor lokale apotheken om de toegang tot zorg in landelijke gebieden te waarborgen.\",\n  \"nl_key_points\": [\n    \"Patiënten kunnen kiezen voor een lokale apotheek voor merkgeneesmiddelen in plaats van alleen postorder.\",\n    \"Apotheken krijgen een vergoeding die de werkelijke inkoopkosten en een standaard verwerkingsfee dekt.\",\n    \"Verbod op verborgen of achteraf berekende kosten die tussenpersonen aan apotheken opleggen.\",\n    \"Jaarlijkse controles op de bereikbaarheid van apotheken, met extra aandacht voor achtergestelde gebieden.\"\n  ],\n  \"pt_ai_title\": \"Medicamentos TRICARE: mais escolha de farmácia e proteção contra taxas ocultas\",\n  \"pt_summary\": \"Esta lei dá aos beneficiários do TRICARE mais liberdade para escolher onde comprar os seus medicamentos de marca. Estabelece regras de pagamento justo para as farmácias locais, melhorando o acesso à saúde em zonas rurais.\",\n  \"pt_key_points\": [\n    \"Os utentes podem optar por levantar medicamentos de marca em farmácias locais em vez de apenas por correio.\",\n    \"As farmácias devem ser reembolsadas pelo custo real do medicamento mais uma taxa de serviço profissional.\",\n    \"Proibição de taxas ocultas ou retroactivas aplicadas por intermediários às farmácias.\",\n    \"Auditorias anuais obrigatórias para garantir que as farmácias são acessíveis em áreas carenciadas.\"\n  ],\n  \"category\": [\n    \"Health\",\n    \"Benefits\",\n    \"Security\"\n  ]\n}\n--- FLAGGED_JSON END ---\n\nOUTPUT:\nWyłącznie naprawiony obiekt JSON zgodny ze strukturą:\n{\n  \"pl_ai_title\": \"...\", \"pl_summary\": \"...\", \"pl_key_points\": [...],\n  \"eng_ai_title\": \"...\", \"eng_summary\": \"...\", \"eng_key_points\": [...],\n  \"de_ai_title\": \"...\", \"de_summary\": \"...\", \"de_key_points\": [...],\n  \"fr_ai_title\": \"...\", \"fr_summary\": \"...\", \"fr_key_points\": [...],\n  \"es_ai_title\": \"...\", \"es_summary\": \"...\", \"es_key_points\": [...],\n  \"it_ai_title\": \"...\", \"it_summary\": \"...\", \"it_key_points\": [...],\n  \"nl_ai_title\": \"...\", \"nl_summary\": \"...\", \"nl_key_points\": [...],\n  \"pt_ai_title\": \"...\", \"pt_summary\": \"...\", \"pt_key_points\": [...],\n  \"category\": [\"...\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Leki w programie TRICARE: większy wybór aptek i ochrona przed ukrytymi kosztami\",\n  \"pl_summary\": \"Ustawa daje osobom korzystającym z programu TRICARE większą swobodę w wyborze miejsca zakupu leków niegenerycznych. Wprowadza również zasady opłacania lokalnych aptek, co ma poprawić dostęp do leków, zwłaszcza na wsiach.\",\n  \"pl_key_points\": [\n    \"Pacjenci mogą wybrać realizację recept na leki niegeneryczne w dowolnej aptece stacjonarnej.\",\n    \"Apteki otrzymają zwrot kosztów pokrywający realną cenę leku oraz standardową opłatę za jego wydanie.\",\n    \"Zakaz nakładania na apteki ukrytych, wstecznych lub dodatkowych opłat przez pośredników.\",\n    \"Coroczne kontrole dostępności aptek dla pacjentów, ze szczególnym uwzględnieniem obszarów wiejskich.\"\n  ],\n  \"eng_ai_title\": \"TRICARE Medications: Greater Pharmacy Choice and Protection from Hidden Costs\",\n  \"eng_summary\": \"This act gives TRICARE beneficiaries more freedom to choose where they purchase non-generic medications. It also establishes payment rules for local pharmacies to improve access to medicine, especially in rural areas.\",\n  \"eng_key_points\": [\n    \"Beneficiaries can choose to fill non-generic maintenance prescriptions at retail pharmacies.\",\n    \"Pharmacies must be reimbursed based on the actual cost of the drug plus a professional dispensing fee.\",\n    \"Middlemen are prohibited from charging pharmacies hidden, retroactive, or point-of-sale fees.\",\n    \"Mandatory annual audits will check if pharmacy networks are adequate and accessible in underserved areas.\"\n  ],\n  \"de_ai_title\": \"TRICARE-Medikamente: Mehr Apothekenwahl und Schutz vor versteckten Kosten\",\n  \"de_summary\": \"Dieses Gesetz gibt TRICARE-Versicherten mehr Freiheit bei der Wahl ihrer Apotheke für nicht-generische Medikamente. Es führt Vergütungsregeln für lokale Apotheken ein, um die Versorgung in ländlichen Gebieten zu sichern.\",\n  \"de_key_points\": [\n    \"Versicherte können nicht-generische Medikamente in lokalen Apotheken beziehen.\",\n    \"Apotheken erhalten eine Erstattung, die den tatsächlichen Einkaufspreis und eine feste Abgabengebühr abdeckt.\",\n    \"Verbot von versteckten oder nachträglichen Gebühren, die Zwischenhändler den Apotheken berechnen.\",\n    \"Jährliche Überprüfung der Erreichbarkeit von Apotheken, insbesondere in ländlichen und unterversorgten Regionen.\"\n  ],\n  \"fr_ai_title\": \"Médicaments TRICARE : plus de choix de pharmacies et protection contre les frais cachés\",\n  \"fr_summary\": \"Cette loi offre aux bénéficiaires de TRICARE une plus grande liberté pour choisir où acheter leurs médicaments non génériques. Elle instaure des règles de paiement pour les pharmacies locales afin d'améliorer l'accès aux soins, surtout en zone rurale.\",\n  \"fr_key_points\": [\n    \"Les patients peuvent choisir de retirer leurs médicaments non génériques en pharmacie physique.\",\n    \"Les pharmacies seront remboursées sur la base du coût réel du médicament plus des frais de service standard.\",\n    \"Interdiction des frais cachés ou rétroactifs imposés aux pharmacies par les intermédiaires.\",\n    \"Audits annuels obligatoires pour garantir l'accessibilité des pharmacies dans les zones mal desservies.\"\n  ],\n  \"es_ai_title\": \"Medicamentos TRICARE: más opciones de farmacia y protección contra cargos ocultos\",\n  \"es_summary\": \"Esta ley otorga a los beneficiarios de TRICARE más libertad para elegir dónde comprar sus medicamentos no genéricos. Establece reglas de pago para las farmacias locales para mejorar el acceso en zonas rurales.\",\n  \"es_key_points\": [\n    \"Los beneficiarios pueden elegir farmacias locales para sus medicamentos no genéricos.\",\n    \"Las farmacias recibirán un reembolso que cubra el costo real del medicamento más una tarifa de despacho profesional.\",\n    \"Se prohíbe a los intermediarios imponer tarifas ocultas o retroactivas a las farmacias.\",\n    \"Auditorías anuales para verificar que el acceso a las farmacias sea suficiente en áreas rurales y desatendidas.\"\n  ],\n  \"it_ai_title\": \"Farmaci TRICARE: più scelta della farmacia e stop ai costi nascosti\",\n  \"it_summary\": \"Questa legge offre ai beneficiari TRICARE maggiore libertà nella scelta di dove acquistare i farmaci non generici. Introduce regole per rimborsi alle farmacie locali, proteggendo l'accesso ai medicinali soprattutto nelle zone rurali.\",\n  \"it_key_points\": [\n    \"I pazienti possono scegliere la farmacia fisica per i farmaci non generici.\",\n    \"Le farmacie devono essere rimborsate in base al costo effettivo del farmaco più una tariffa professionale.\",\n    \"Divieto di commissioni nascoste o retroattive applicate dagli intermediari alle farmacie.\",\n    \"Controlli annuali sulla rete delle farmacie per garantire la copertura nelle zone meno servite.\"\n  ],\n  \"nl_ai_title\": \"TRICARE-medicijnen: meer apotheekkeuze en bescherming tegen verborgen kosten\",\n  \"nl_summary\": \"Deze wet geeft TRICARE-verzekerden meer vrijheid om te kiezen waar ze hun niet-generieke geneesmiddelen kopen. Het voert betalingsregels in voor lokale apotheken om de toegang tot zorg in landelijke gebieden te waarborgen.\",\n  \"nl_key_points\": [\n    \"Patiënten kunnen kiezen voor een lokale apotheek voor niet-generieke geneesmiddelen.\",\n    \"Apotheken krijgen een vergoeding die de werkelijke inkoopkosten en een standaard verwerkingsfee dekt.\",\n    \"Verbod op verborgen of achteraf berekende kosten die tussenpersonen aan apotheken opleggen.\",\n    \"Jaarlijkse controles op de bereikbaarheid van apotheken, met extra aandacht voor achtergestelde gebieden.\"\n  ],\n  \"pt_ai_title\": \"Medicamentos TRICARE: mais escolha de farmácia e proteção contra taxas ocultas\",\n  \"pt_summary\": \"Esta lei dá aos beneficiários do TRICARE mais liberdade para escolher onde comprar os seus medicamentos não genéricos. Estabelece regras de pagamento para as farmácias locais, melhorando o acesso à saúde em zonas rurais.\",\n  \"pt_key_points\": [\n    \"Os utentes podem optar por levantar medicamentos não genéricos em farmácias locais.\",\n    \"As farmácias devem ser reembolsadas pelo custo real do medicamento mais uma taxa de serviço profissional.\",\n    \"Proibição de taxas ocultas ou retroactivas aplicadas por intermediários às farmácias.\",\n    \"Auditorias anuais obrigatórias para garantir que as farmácias são acessíveis em áreas carenciadas.\"\n  ],\n  \"category\": [\n    \"Health\",\n    \"Benefits\",\n    \"Security\"\n  ]\n}"
    },
    {
      "timestamp": "2026-03-26T12:34:00.897Z",
      "source_url": "https://www.congress.gov/119/bills/s4106/BILLS-119s4106is.htm",
      "model": "gemini-flash-lite-latest",
      "prompt_sent": "\nROLE: Fact Checker.\nZADANIE: Porównaj SOURCE (oryginał) i SUMMARY (streszczenie przygotowane przez inne AI).\n\nTwoim celem jest wykrycie \"ZMYŚLONYCH KONKRETÓW\" (Fabricated Entities) w SUMMARY.\n\nSOURCE:\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 4106 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 4106 To amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES March 17, 2026 Mr. Cotton (for himself and Mr. Kaine) introduced the following bill; which was read twice and referred to the Committee on the Judiciary _______________________________________________________________________ A BILL To amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Rx Access, Choice, Cost Equity, and Supply Stability Act'' or the ``Rx ACCESS Act''. SEC. 2. IMPROVEMENTS RELATING TO ACCESS, FAIRNESS, AND TRANSPARENCY UNDER TRICARE PHARMACY BENEFITS PROGRAM. (a) Beneficiary Election of Prescription Refill Means.--Section 1074g(a)(9) of title 10, United States Code, is amended-- (1) in subparagraph (A), by inserting ``, and ending on October 1, 2026'' after ``Beginning on October 1, 2015''; and (2) by adding at the end the following new subparagraph: ``(D) Beginning on October 1, 2026, an eligible covered beneficiary may elect to receive non-generic prescription maintenance medications through any means described in paragraph (2)(E).''. (b) Pharmacy Benefit Manager Reimbursement Standards; Independent Audits.--Section 1074g of title 10, United States Code, as amended by subsection (a), is further amended-- (1) by redesignating subsections (i) and (j) as subsections (j) and (k), respectively; and (2) by inserting after subsection (h) the following new subsection: ``(i) Pharmacy Benefit Manager Reimbursement Standards.--(1) The Secretary of Defense shall ensure that, as a condition of any contract entered into for the administration of the pharmacy benefits program, reimbursement to a retail pharmacy described in subsection (a)(2)(E)(ii) for a pharmaceutical agent provided under such program shall be an amount that is equal to not less than the sum of-- ``(A) either-- ``(i) the actual cost to the pharmacy of acquiring such pharmaceutical agent from a wholesaler, or ``(ii) in the case of a pharmaceutical agent included on the national average drug acquisition cost index published by the Administrator of the Centers for Medicare & Medicaid Services, a proxy amount calculated at a rate that is not lower than the national average acquisition cost for such pharmaceutical agent, as identified on such cost index as of the date of the adjudication of the claim for such reimbursement, and ``(B) a professional dispensing fee that is equal to the professional dispensing fee paid by the State in which the pharmacy is located under title XIX of the Social Security Act (42 U.S.C. 1396 et seq.) for dispensing a prescription drug. ``(2) The contractor administering the pharmacy benefits program may not impose any fees on a retail pharmacy described in subsection (a)(2)(E)(ii), including point-of-sale fees, retroactive fees, or other indirect or hidden fees. ``(3)(A) Not less frequently than annually, the Comptroller General of the United States shall-- ``(i) conduct an audit of-- ``(I) data reported by the contractor responsible for the administration of the pharmacy benefits program relating to the rates of reimbursement under paragraph (1) and any price concessions; and ``(II) the adequacy of the retail pharmacy network under the TRICARE program and access by eligible covered beneficiaries to such network, including with respect to continuity of care, geographic accessibility (taking into account factors in addition to travel time to and from a pharmacy, with special consideration for rural and underserved areas), and the extent to which elections by such beneficiaries under subsection (a)(9) reflect personal preference; and ``(ii) submit the results of such audit to the Committee on Armed Services of the Senate and the Committee on Armed Services of the House of Representatives. ``(B) The Secretary shall ensure that, as a condition of any contract entered into for the administration of the pharmacy benefits program, the contractor provides the Comptroller General information required to conduct the audit under subparagraph (A).''. (c) Report.--Not later than 90 days after the date of the enactment of this Act, the Secretary of Defense shall submit to the congressional defense committees (as defined in section 101(a)(16) of title 10, United States Code) a plan for the implementation of this section. <all>\n\nSUMMARY TO EVALUATE:\nTitle: TRICARE Medications: Greater Pharmacy Choice and Protection from Hidden Costs\nSummary: This act gives TRICARE beneficiaries more freedom to choose where they purchase brand-name medications. It also establishes fair payment rules for local pharmacies to prevent closures and improve access to medicine, especially in rural areas.\nKey Points: Beneficiaries can choose to fill brand-name maintenance prescriptions at retail pharmacies instead of mail-order only., Pharmacies must be reimbursed based on the actual cost of the drug plus a professional dispensing fee., Middlemen are prohibited from charging pharmacies hidden, retroactive, or point-of-sale fees., Mandatory annual audits will check if pharmacy networks are adequate and accessible in underserved areas.\n\nZASADY OCENY:\n1. Sprawdź wszystkie LICZBY, DATY i KWOTY w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n2. Sprawdź wszystkie NAZWISKA, ORGANIZACJE i MIEJSCA w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n3. Sprawdź wszystkie konkretne DZIAŁANIA PRAWNE . Jeśli tego mechanizmu nie ma w SOURCE -> is_valid: false.\n\nWAŻNE: Abstrakcyjne pojęcia (np. \"transparentność\", \"zaufanie\") są dozwolone jako wnioski.\n\nOUTPUT (JSON):\n{\n  \"is_valid\": true/false,\n  \"issue\": \"fabricated_entity\" / \"contradiction\" / \"none\"\n}\n\nWYMAGANIA FORMATOWANIA:\n1. Odpowiedz WYŁĄCZNIE surowym obiektem JSON.\n2. NIE używaj bloków kodu Markdown.\n3. NIE dodawaj żadnych wstępów ani wyjaśnień przed ani po JSONie.\n4. JSON musi być poprawny i gotowy do parsowania.\n\n",
      "ai_response_raw": "{\n  \"is_valid\": false,\n  \"issue\": \"fabricated_entity\"\n}"
    },
    {
      "timestamp": "2026-03-26T12:23:14.489Z",
      "source_url": "https://www.congress.gov/119/bills/s4106/BILLS-119s4106is.htm",
      "model": "gemini-flash-latest",
      "prompt_sent": "\nJesteś ekspertem od prawa Stanów Zjednoczonych, który ma za zadanie analizować dokumenty ustaw, uchwał oraz innych dokumentów legislacyjnych, a następnie przygotowywać z nich informacje w przystępny sposób dla obywateli. Twoim celem jest przedstawienie informacji tak, aby obywatele mogli sami ocenić wpływ legislacji na ich życie, nawet bez posiadania specjalistycznej wiedzy legislacyjnej. Skup się na faktach i obiektywnych skutkach wprowadzanych zmian, unikając wartościowania i osobistych opinii. Wszelki żargon prawny jest zabroniony. Prezentuj informacje w jasny, zwięzły i angażujący sposób, tak aby były zrozumiałe dla osoby bez wykształcenia prawniczego. Unikaj długich, złożonych zdań. Zamiast pisać \"projekt ma na celu nowelizację kodeksu podatkowego...\", napisz \"Zmiany w podatkach: nowe ulgi i obowiązki dla...\". Kontynuuj swoją pracę, dopóki nie rozwiążesz swojego zadania. Jeśli nie masz pewności co do generowanej treści, przeanalizuj dokument ponownie – nie zgaduj. Rozplanuj dobrze swoje zadanie przed przystąpieniem do niego. W podsumowaniu i kluczowych punktach, jeśli to możliwe i uzasadnione, podkreśl, jakie konkretne korzyści lub skutki (pozytywne lub negatywne) wprowadza ustawa dla życia codziennego obywateli, ich praw i obowiązków, finansów osobistych, bezpieczeństwa i innych ważnych kwestii (np. kategorycznych zakazów i nakazów czy najważniejszych konkretnych alokacji finansowych i terytorialnych).\n\nTwoja odpowiedź MUSI być w formacie JSON - i zawierać następujące klucze.\nZanim zwrócisz odpowiedź, dokładnie zweryfikuj, czy cała struktura JSON jest w 100% poprawna, włącznie ze wszystkimi przecinkami, nawiasami klamrowymi, kwadratowymi oraz cudzysłowami. Błędny JSON jest nieakceptowalny i uniemożliwi przetworzenie Twojej pracy.\n\nPrzeanalizuj dokładnie poniższy tekst dokumentu prawnego. To jest treść, na podstawie której masz wygenerować podsumowanie i kluczowe punkty:\n--- POCZĄTEK DOKUMENTU ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 4106 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 4106 To amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES March 17, 2026 Mr. Cotton (for himself and Mr. Kaine) introduced the following bill; which was read twice and referred to the Committee on the Judiciary _______________________________________________________________________ A BILL To amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Rx Access, Choice, Cost Equity, and Supply Stability Act'' or the ``Rx ACCESS Act''. SEC. 2. IMPROVEMENTS RELATING TO ACCESS, FAIRNESS, AND TRANSPARENCY UNDER TRICARE PHARMACY BENEFITS PROGRAM. (a) Beneficiary Election of Prescription Refill Means.--Section 1074g(a)(9) of title 10, United States Code, is amended-- (1) in subparagraph (A), by inserting ``, and ending on October 1, 2026'' after ``Beginning on October 1, 2015''; and (2) by adding at the end the following new subparagraph: ``(D) Beginning on October 1, 2026, an eligible covered beneficiary may elect to receive non-generic prescription maintenance medications through any means described in paragraph (2)(E).''. (b) Pharmacy Benefit Manager Reimbursement Standards; Independent Audits.--Section 1074g of title 10, United States Code, as amended by subsection (a), is further amended-- (1) by redesignating subsections (i) and (j) as subsections (j) and (k), respectively; and (2) by inserting after subsection (h) the following new subsection: ``(i) Pharmacy Benefit Manager Reimbursement Standards.--(1) The Secretary of Defense shall ensure that, as a condition of any contract entered into for the administration of the pharmacy benefits program, reimbursement to a retail pharmacy described in subsection (a)(2)(E)(ii) for a pharmaceutical agent provided under such program shall be an amount that is equal to not less than the sum of-- ``(A) either-- ``(i) the actual cost to the pharmacy of acquiring such pharmaceutical agent from a wholesaler, or ``(ii) in the case of a pharmaceutical agent included on the national average drug acquisition cost index published by the Administrator of the Centers for Medicare & Medicaid Services, a proxy amount calculated at a rate that is not lower than the national average acquisition cost for such pharmaceutical agent, as identified on such cost index as of the date of the adjudication of the claim for such reimbursement, and ``(B) a professional dispensing fee that is equal to the professional dispensing fee paid by the State in which the pharmacy is located under title XIX of the Social Security Act (42 U.S.C. 1396 et seq.) for dispensing a prescription drug. ``(2) The contractor administering the pharmacy benefits program may not impose any fees on a retail pharmacy described in subsection (a)(2)(E)(ii), including point-of-sale fees, retroactive fees, or other indirect or hidden fees. ``(3)(A) Not less frequently than annually, the Comptroller General of the United States shall-- ``(i) conduct an audit of-- ``(I) data reported by the contractor responsible for the administration of the pharmacy benefits program relating to the rates of reimbursement under paragraph (1) and any price concessions; and ``(II) the adequacy of the retail pharmacy network under the TRICARE program and access by eligible covered beneficiaries to such network, including with respect to continuity of care, geographic accessibility (taking into account factors in addition to travel time to and from a pharmacy, with special consideration for rural and underserved areas), and the extent to which elections by such beneficiaries under subsection (a)(9) reflect personal preference; and ``(ii) submit the results of such audit to the Committee on Armed Services of the Senate and the Committee on Armed Services of the House of Representatives. ``(B) The Secretary shall ensure that, as a condition of any contract entered into for the administration of the pharmacy benefits program, the contractor provides the Comptroller General information required to conduct the audit under subparagraph (A).''. (c) Report.--Not later than 90 days after the date of the enactment of this Act, the Secretary of Defense shall submit to the congressional defense committees (as defined in section 101(a)(16) of title 10, United States Code) a plan for the implementation of this section. <all>\n--- KONIEC DOKUMENTU ---\n\nPAMIĘTAJ: Twoja odpowiedź MUSI być wyłącznie poprawnym obiektem JSON. Nie dodawaj żadnych dodatkowych znaków, komentarzy ani tekstu przed znacznikiem '{' ani po znaczniku '}'. Cała odpowiedź musi być parsowalna jako JSON.\nNa podstawie POWYŻSZEGO dokumentu, wypełnij poniższą strukturę JSON:\nOto struktura JSON, której oczekuję (wypełnij ją treścią):\n{\n  \"pl_ai_title\": \"Nowy, krótki tytuł dla aktu prawnego po polsku, oddający sedno wprowadzanych zmian (np. maksymalnie 10-12 słów).\",\n  \"pl_summary\": \"2-3 zdania zwięzłego podsumowania treści aktu prawnego po polsku, napisane z perspektywy wpływu na życie codzienne obywateli.\",\n  \"pl_key_points\": [\n    \"Pierwszy krótki punkt po polsku dotyczący najważniejszych wprowadzanych rozwiązań lub zmian.\",\n    \"Drugi krótki punkt po polsku...\"\n  ],\n  \"eng_ai_title\": \"A new, short title for the legal act in English, capturing the essence of the changes (e.g., max 10-12 words).\",\n  \"eng_summary\": \"2-3 sentences summarizing the legal act in English, from the perspective of its impact on citizens' daily lives.\",\n  \"eng_key_points\": [\n    \"First short bullet point in English regarding the most important solutions or changes being introduced.\",\n    \"Second short bullet point in English...\"\n  ],\n  \"de_ai_title\": \"Ein neuer, kurzer Titel für das Rechtsdokument auf Deutsch, der den Kern der Änderungen erfasst (z.B. max. 10-12 Wörter).\",\n  \"de_summary\": \"2-3 Sätze Zusammenfassung des Rechtsdokuments auf Deutsch, aus der Perspektive seiner Auswirkungen auf das tägliche Leben der Bürger.\",\n  \"de_key_points\": [\n    \"Erster kurzer Stichpunkt auf Deutsch zu den wichtigsten eingeführten Lösungen oder Änderungen.\",\n    \"Zweiter kurzer Stichpunkt auf Deutsch...\"\n  ],\n  \"fr_ai_title\": \"Un nouveau titre court pour l'acte juridique en français, saisissant l'essence des changements (par exemple, 10-12 mots maximum).\",\n  \"fr_summary\": \"Résumé de 2-3 phrases de l'acte juridique en français, du point de vue de son impact sur la vie quotidienne des citoyens.\",\n  \"fr_key_points\": [\n    \"Premier court point en français concernant les solutions ou changements les plus importants introduits.\",\n    \"Deuxième court point en français...\"\n  ],\n  \"es_ai_title\": \"Un nuevo título breve para el acto jurídico en español, que recoja la esencia de los cambios (por ejemplo, máximo 10-12 palabras).\",\n  \"es_summary\": \"Resumen de 2-3 frases del acto jurídico en español, desde la perspectiva de su impacto en la vida cotidiana de los ciudadanos.\",\n  \"es_key_points\": [\n    \"Primer punto breve en español sobre las soluciones o cambios más importantes que se introducen.\",\n    \"Segundo punto breve en español...\"\n  ],\n  \"it_ai_title\": \"Un nuovo titolo breve per l'atto giuridico in italiano, che colga l'essenza delle modifiche (ad es. massimo 10-12 parole).\",\n  \"it_summary\": \"Riepilogo di 2-3 frasi dell'atto giuridico in italiano, dal punto di vista del suo impatto sulla vita quotidiana dei cittadini.\",\n  \"it_key_points\": [\n    \"Primo breve punto in italiano riguardante le soluzioni o le modifiche più importanti introdotte.\",\n    \"Secondo breve punto in italiano...\"\n  ],\n  \"nl_ai_title\": \"Een nieuwe, korte titel voor de rechtshandeling in het Nederlands, die de essentie van de wijzigingen weergeeft (bijv. max. 10-12 woorden).\",\n  \"nl_summary\": \"Samenvatting van 2-3 zinnen van de rechtshandeling in het Nederlands, vanuit het perspectief van de impact op het dagelijks leven van burgers.\",\n  \"nl_key_points\": [\n    \"Eerste korte punt in het Nederlands betreffende de belangrijkste geïntroduceerde oplossingen of wijzigingen.\",\n    \"Tweede korte punt in het Nederlands...\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Primeiro ponto curto em português sobre as soluções ou alterações mais importantes introduzidas.\",\n    \"Segundo ponto curto em português...\"\n  ],\n  \"category\": [\"Categorize the document into one category by default, based on the field it primarily concerns. Choose up to 3 if the document also touches upon SIGNIFICANT issues from other categories. You MUST select categories ONLY from the following list: Health, Education, Family, Taxes, Labor, Security, Environment, Courts and Law, Transport, Benefits, Real Estate, Media and Culture, Local Government, Migration, Agriculture, Public Investments, Informatization, Economy. If the document does not definitively fit any of these, you MUST use \"Other\". If you use \"Other\", it should be the ONLY category selected. Do NOT invent new categories. The response must be an array of strings, e.g., [\"Taxes\", \"Family\"].\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Leki w programie TRICARE: większy wybór aptek i ochrona przed ukrytymi kosztami\",\n  \"pl_summary\": \"Ustawa daje osobom korzystającym z programu TRICARE większą swobodę w wyborze miejsca zakupu leków markowych. Wprowadza również zasady uczciwego opłacania lokalnych aptek, co ma zapobiec ich zamykaniu i poprawić dostęp do leków, zwłaszcza na wsiach.\",\n  \"pl_key_points\": [\n    \"Pacjenci mogą wybrać realizację recept na leki markowe w dowolnej aptece stacjonarnej zamiast tylko wysyłkowej.\",\n    \"Apteki otrzymają zwrot kosztów pokrywający realną cenę leku oraz standardową opłatę za jego wydanie.\",\n    \"Zakaz nakładania na apteki ukrytych, wstecznych lub dodatkowych opłat przez pośredników.\",\n    \"Coroczne kontrole dostępności aptek dla pacjentów, ze szczególnym uwzględnieniem obszarów wiejskich.\"\n  ],\n  \"eng_ai_title\": \"TRICARE Medications: Greater Pharmacy Choice and Protection from Hidden Costs\",\n  \"eng_summary\": \"This act gives TRICARE beneficiaries more freedom to choose where they purchase brand-name medications. It also establishes fair payment rules for local pharmacies to prevent closures and improve access to medicine, especially in rural areas.\",\n  \"eng_key_points\": [\n    \"Beneficiaries can choose to fill brand-name maintenance prescriptions at retail pharmacies instead of mail-order only.\",\n    \"Pharmacies must be reimbursed based on the actual cost of the drug plus a professional dispensing fee.\",\n    \"Middlemen are prohibited from charging pharmacies hidden, retroactive, or point-of-sale fees.\",\n    \"Mandatory annual audits will check if pharmacy networks are adequate and accessible in underserved areas.\"\n  ],\n  \"de_ai_title\": \"TRICARE-Medikamente: Mehr Apothekenwahl und Schutz vor versteckten Kosten\",\n  \"de_summary\": \"Dieses Gesetz gibt TRICARE-Versicherten mehr Freiheit bei der Wahl ihrer Apotheke für Markenmedikamente. Es führt faire Vergütungsregeln für lokale Apotheken ein, um deren Schließung zu verhindern und die Versorgung in ländlichen Gebieten zu sichern.\",\n  \"de_key_points\": [\n    \"Versicherte können Markenmedikamente in lokalen Apotheken statt nur per Versandhandel beziehen.\",\n    \"Apotheken erhalten eine Erstattung, die den tatsächlichen Einkaufspreis und eine feste Abgabengebühr abdeckt.\",\n    \"Verbot von versteckten oder nachträglichen Gebühren, die Zwischenhändler den Apotheken berechnen.\",\n    \"Jährliche Überprüfung der Erreichbarkeit von Apotheken, insbesondere in ländlichen und unterversorgten Regionen.\"\n  ],\n  \"fr_ai_title\": \"Médicaments TRICARE : plus de choix de pharmacies et protection contre les frais cachés\",\n  \"fr_summary\": \"Cette loi offre aux bénéficiaires de TRICARE une plus grande liberté pour choisir où acheter leurs médicaments de marque. Elle instaure des règles de paiement équitables pour les pharmacies locales afin d'améliorer l'accès aux soins, surtout en zone rurale.\",\n  \"fr_key_points\": [\n    \"Les patients peuvent choisir de retirer leurs médicaments de marque en pharmacie physique plutôt que par correspondance.\",\n    \"Les pharmacies seront remboursées sur la base du coût réel du médicament plus des frais de service standard.\",\n    \"Interdiction des frais cachés ou rétroactifs imposés aux pharmacies par les intermédiaires.\",\n    \"Audits annuels obligatoires pour garantir l'accessibilité des pharmacies dans les zones mal desservies.\"\n  ],\n  \"es_ai_title\": \"Medicamentos TRICARE: más opciones de farmacia y protección contra cargos ocultos\",\n  \"es_summary\": \"Esta ley otorga a los beneficiarios de TRICARE más libertad para elegir dónde comprar sus medicamentos de marca. Establece reglas de pago justo para las farmacias locales para evitar cierres y mejorar el acceso en zonas rurales.\",\n  \"es_key_points\": [\n    \"Los beneficiarios pueden elegir farmacias locales para sus medicamentos de marca en lugar de solo el envío por correo.\",\n    \"Las farmacias recibirán un reembolso que cubra el costo real del medicamento más una tarifa de despacho profesional.\",\n    \"Se prohíbe a los intermediarios imponer tarifas ocultas o retroactivas a las farmacias.\",\n    \"Auditorías anuales para verificar que el acceso a las farmacias sea suficiente en áreas rurales y desatendidas.\"\n  ],\n  \"it_ai_title\": \"Farmaci TRICARE: più scelta della farmacia e stop ai costi nascosti\",\n  \"it_summary\": \"Questa legge offre ai beneficiari TRICARE maggiore libertà nella scelta di dove acquistare i farmaci di marca. Introduce regole per rimborsi equi alle farmacie locali, proteggendo l'accesso ai medicinali soprattutto nelle zone rurali.\",\n  \"it_key_points\": [\n    \"I pazienti possono scegliere la farmacia fisica per i farmaci di marca invece dell'obbligo di spedizione a domicilio.\",\n    \"Le farmacie devono essere rimborsate in base al costo effettivo del farmaco più una tariffa professionale.\",\n    \"Divieto di commissioni nascoste o retroattive applicate dagli intermediari alle farmacie.\",\n    \"Controlli annuali sulla rete delle farmacie per garantire la copertura nelle zone meno servite.\"\n  ],\n  \"nl_ai_title\": \"TRICARE-medicijnen: meer apotheekkeuze en bescherming tegen verborgen kosten\",\n  \"nl_summary\": \"Deze wet geeft TRICARE-verzekerden meer vrijheid om te kiezen waar ze hun merkgeneesmiddelen kopen. Het voert eerlijke betalingsregels in voor lokale apotheken om de toegang tot zorg in landelijke gebieden te waarborgen.\",\n  \"nl_key_points\": [\n    \"Patiënten kunnen kiezen voor een lokale apotheek voor merkgeneesmiddelen in plaats van alleen postorder.\",\n    \"Apotheken krijgen een vergoeding die de werkelijke inkoopkosten en een standaard verwerkingsfee dekt.\",\n    \"Verbod op verborgen of achteraf berekende kosten die tussenpersonen aan apotheken opleggen.\",\n    \"Jaarlijkse controles op de bereikbaarheid van apotheken, met extra aandacht voor achtergestelde gebieden.\"\n  ],\n  \"pt_ai_title\": \"Medicamentos TRICARE: mais escolha de farmácia e proteção contra taxas ocultas\",\n  \"pt_summary\": \"Esta lei dá aos beneficiários do TRICARE mais liberdade para escolher onde comprar os seus medicamentos de marca. Estabelece regras de pagamento justo para as farmácias locais, melhorando o acesso à saúde em zonas rurais.\",\n  \"pt_key_points\": [\n    \"Os utentes podem optar por levantar medicamentos de marca em farmácias locais em vez de apenas por correio.\",\n    \"As farmácias devem ser reembolsadas pelo custo real do medicamento mais uma taxa de serviço profissional.\",\n    \"Proibição de taxas ocultas ou retroactivas aplicadas por intermediários às farmácias.\",\n    \"Auditorias anuais obrigatórias para garantir que as farmácias são acessíveis em áreas carenciadas.\"\n  ],\n  \"category\": [\"Health\", \"Benefits\", \"Security\"]\n}"
    },
    {
      "timestamp": "2026-03-25T12:33:27.510Z",
      "source_url": "https://www.congress.gov/119/bills/s4106/BILLS-119s4106is.htm",
      "model": "gemini-flash-lite-latest",
      "prompt_sent": "\nROLE: Fact Checker.\nZADANIE: Porównaj SOURCE (oryginał) i SUMMARY (streszczenie przygotowane przez inne AI).\n\nTwoim celem jest wykrycie \"ZMYŚLONYCH KONKRETÓW\" (Fabricated Entities) w SUMMARY.\n\nSOURCE:\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 4106 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 4106 To amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES March 17, 2026 Mr. Cotton (for himself and Mr. Kaine) introduced the following bill; which was read twice and referred to the Committee on the Judiciary _______________________________________________________________________ A BILL To amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Rx Access, Choice, Cost Equity, and Supply Stability Act'' or the ``Rx ACCESS Act''. SEC. 2. IMPROVEMENTS RELATING TO ACCESS, FAIRNESS, AND TRANSPARENCY UNDER TRICARE PHARMACY BENEFITS PROGRAM. (a) Beneficiary Election of Prescription Refill Means.--Section 1074g(a)(9) of title 10, United States Code, is amended-- (1) in subparagraph (A), by inserting ``, and ending on October 1, 2026'' after ``Beginning on October 1, 2015''; and (2) by adding at the end the following new subparagraph: ``(D) Beginning on October 1, 2026, an eligible covered beneficiary may elect to receive non-generic prescription maintenance medications through any means described in paragraph (2)(E).''. (b) Pharmacy Benefit Manager Reimbursement Standards; Independent Audits.--Section 1074g of title 10, United States Code, as amended by subsection (a), is further amended-- (1) by redesignating subsections (i) and (j) as subsections (j) and (k), respectively; and (2) by inserting after subsection (h) the following new subsection: ``(i) Pharmacy Benefit Manager Reimbursement Standards.--(1) The Secretary of Defense shall ensure that, as a condition of any contract entered into for the administration of the pharmacy benefits program, reimbursement to a retail pharmacy described in subsection (a)(2)(E)(ii) for a pharmaceutical agent provided under such program shall be an amount that is equal to not less than the sum of-- ``(A) either-- ``(i) the actual cost to the pharmacy of acquiring such pharmaceutical agent from a wholesaler, or ``(ii) in the case of a pharmaceutical agent included on the national average drug acquisition cost index published by the Administrator of the Centers for Medicare & Medicaid Services, a proxy amount calculated at a rate that is not lower than the national average acquisition cost for such pharmaceutical agent, as identified on such cost index as of the date of the adjudication of the claim for such reimbursement, and ``(B) a professional dispensing fee that is equal to the professional dispensing fee paid by the State in which the pharmacy is located under title XIX of the Social Security Act (42 U.S.C. 1396 et seq.) for dispensing a prescription drug. ``(2) The contractor administering the pharmacy benefits program may not impose any fees on a retail pharmacy described in subsection (a)(2)(E)(ii), including point-of-sale fees, retroactive fees, or other indirect or hidden fees. ``(3)(A) Not less frequently than annually, the Comptroller General of the United States shall-- ``(i) conduct an audit of-- ``(I) data reported by the contractor responsible for the administration of the pharmacy benefits program relating to the rates of reimbursement under paragraph (1) and any price concessions; and ``(II) the adequacy of the retail pharmacy network under the TRICARE program and access by eligible covered beneficiaries to such network, including with respect to continuity of care, geographic accessibility (taking into account factors in addition to travel time to and from a pharmacy, with special consideration for rural and underserved areas), and the extent to which elections by such beneficiaries under subsection (a)(9) reflect personal preference; and ``(ii) submit the results of such audit to the Committee on Armed Services of the Senate and the Committee on Armed Services of the House of Representatives. ``(B) The Secretary shall ensure that, as a condition of any contract entered into for the administration of the pharmacy benefits program, the contractor provides the Comptroller General information required to conduct the audit under subparagraph (A).''. (c) Report.--Not later than 90 days after the date of the enactment of this Act, the Secretary of Defense shall submit to the congressional defense committees (as defined in section 101(a)(16) of title 10, United States Code) a plan for the implementation of this section. <all>\n\nSUMMARY TO EVALUATE:\nTitle: TRICARE Medications: Greater Pharmacy Choice and Protection from Hidden Costs\nSummary: This act gives TRICARE beneficiaries more freedom to choose where they purchase brand-name medications. It also establishes fair payment rules for local pharmacies to prevent closures and improve access to medicine, especially in rural areas.\nKey Points: Beneficiaries can choose to fill brand-name maintenance prescriptions at retail pharmacies instead of mail-order only., Pharmacies must be reimbursed based on the actual cost of the drug plus a professional dispensing fee., Middlemen are prohibited from charging pharmacies hidden, retroactive, or point-of-sale fees., Mandatory annual audits will check if pharmacy networks are adequate and accessible in underserved areas.\n\nZASADY OCENY:\n1. Sprawdź wszystkie LICZBY, DATY i KWOTY w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n2. Sprawdź wszystkie NAZWISKA, ORGANIZACJE i MIEJSCA w SUMMARY. Jeśli którejś brakuje w SOURCE -> is_valid: false.\n3. Sprawdź wszystkie konkretne DZIAŁANIA PRAWNE . Jeśli tego mechanizmu nie ma w SOURCE -> is_valid: false.\n\nWAŻNE: Abstrakcyjne pojęcia (np. \"transparentność\", \"zaufanie\") są dozwolone jako wnioski.\n\nOUTPUT (JSON):\n{\n  \"is_valid\": true/false,\n  \"issue\": \"fabricated_entity\" / \"contradiction\" / \"none\"\n}\n\nWYMAGANIA FORMATOWANIA:\n1. Odpowiedz WYŁĄCZNIE surowym obiektem JSON.\n2. NIE używaj bloków kodu Markdown.\n3. NIE dodawaj żadnych wstępów ani wyjaśnień przed ani po JSONie.\n4. JSON musi być poprawny i gotowy do parsowania.\n\n",
      "ai_response_raw": "{\n  \"is_valid\": false,\n  \"issue\": \"fabricated_entity\"\n}"
    },
    {
      "timestamp": "2026-03-25T12:21:50.426Z",
      "source_url": "https://www.congress.gov/119/bills/s4106/BILLS-119s4106is.htm",
      "model": "gemini-flash-latest",
      "prompt_sent": "\nJesteś ekspertem od prawa Stanów Zjednoczonych, który ma za zadanie analizować dokumenty ustaw, uchwał oraz innych dokumentów legislacyjnych, a następnie przygotowywać z nich informacje w przystępny sposób dla obywateli. Twoim celem jest przedstawienie informacji tak, aby obywatele mogli sami ocenić wpływ legislacji na ich życie, nawet bez posiadania specjalistycznej wiedzy legislacyjnej. Skup się na faktach i obiektywnych skutkach wprowadzanych zmian, unikając wartościowania i osobistych opinii. Wszelki żargon prawny jest zabroniony. Prezentuj informacje w jasny, zwięzły i angażujący sposób, tak aby były zrozumiałe dla osoby bez wykształcenia prawniczego. Unikaj długich, złożonych zdań. Zamiast pisać \"projekt ma na celu nowelizację kodeksu podatkowego...\", napisz \"Zmiany w podatkach: nowe ulgi i obowiązki dla...\". Kontynuuj swoją pracę, dopóki nie rozwiążesz swojego zadania. Jeśli nie masz pewności co do generowanej treści, przeanalizuj dokument ponownie – nie zgaduj. Rozplanuj dobrze swoje zadanie przed przystąpieniem do niego. W podsumowaniu i kluczowych punktach, jeśli to możliwe i uzasadnione, podkreśl, jakie konkretne korzyści lub skutki (pozytywne lub negatywne) wprowadza ustawa dla życia codziennego obywateli, ich praw i obowiązków, finansów osobistych, bezpieczeństwa i innych ważnych kwestii (np. kategorycznych zakazów i nakazów czy najważniejszych konkretnych alokacji finansowych i terytorialnych).\n\nTwoja odpowiedź MUSI być w formacie JSON - i zawierać następujące klucze.\nZanim zwrócisz odpowiedź, dokładnie zweryfikuj, czy cała struktura JSON jest w 100% poprawna, włącznie ze wszystkimi przecinkami, nawiasami klamrowymi, kwadratowymi oraz cudzysłowami. Błędny JSON jest nieakceptowalny i uniemożliwi przetworzenie Twojej pracy.\n\nPrzeanalizuj dokładnie poniższy tekst dokumentu prawnego. To jest treść, na podstawie której masz wygenerować podsumowanie i kluczowe punkty:\n--- POCZĄTEK DOKUMENTU ---\n[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 4106 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 4106 To amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES March 17, 2026 Mr. Cotton (for himself and Mr. Kaine) introduced the following bill; which was read twice and referred to the Committee on the Judiciary _______________________________________________________________________ A BILL To amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Rx Access, Choice, Cost Equity, and Supply Stability Act'' or the ``Rx ACCESS Act''. SEC. 2. IMPROVEMENTS RELATING TO ACCESS, FAIRNESS, AND TRANSPARENCY UNDER TRICARE PHARMACY BENEFITS PROGRAM. (a) Beneficiary Election of Prescription Refill Means.--Section 1074g(a)(9) of title 10, United States Code, is amended-- (1) in subparagraph (A), by inserting ``, and ending on October 1, 2026'' after ``Beginning on October 1, 2015''; and (2) by adding at the end the following new subparagraph: ``(D) Beginning on October 1, 2026, an eligible covered beneficiary may elect to receive non-generic prescription maintenance medications through any means described in paragraph (2)(E).''. (b) Pharmacy Benefit Manager Reimbursement Standards; Independent Audits.--Section 1074g of title 10, United States Code, as amended by subsection (a), is further amended-- (1) by redesignating subsections (i) and (j) as subsections (j) and (k), respectively; and (2) by inserting after subsection (h) the following new subsection: ``(i) Pharmacy Benefit Manager Reimbursement Standards.--(1) The Secretary of Defense shall ensure that, as a condition of any contract entered into for the administration of the pharmacy benefits program, reimbursement to a retail pharmacy described in subsection (a)(2)(E)(ii) for a pharmaceutical agent provided under such program shall be an amount that is equal to not less than the sum of-- ``(A) either-- ``(i) the actual cost to the pharmacy of acquiring such pharmaceutical agent from a wholesaler, or ``(ii) in the case of a pharmaceutical agent included on the national average drug acquisition cost index published by the Administrator of the Centers for Medicare & Medicaid Services, a proxy amount calculated at a rate that is not lower than the national average acquisition cost for such pharmaceutical agent, as identified on such cost index as of the date of the adjudication of the claim for such reimbursement, and ``(B) a professional dispensing fee that is equal to the professional dispensing fee paid by the State in which the pharmacy is located under title XIX of the Social Security Act (42 U.S.C. 1396 et seq.) for dispensing a prescription drug. ``(2) The contractor administering the pharmacy benefits program may not impose any fees on a retail pharmacy described in subsection (a)(2)(E)(ii), including point-of-sale fees, retroactive fees, or other indirect or hidden fees. ``(3)(A) Not less frequently than annually, the Comptroller General of the United States shall-- ``(i) conduct an audit of-- ``(I) data reported by the contractor responsible for the administration of the pharmacy benefits program relating to the rates of reimbursement under paragraph (1) and any price concessions; and ``(II) the adequacy of the retail pharmacy network under the TRICARE program and access by eligible covered beneficiaries to such network, including with respect to continuity of care, geographic accessibility (taking into account factors in addition to travel time to and from a pharmacy, with special consideration for rural and underserved areas), and the extent to which elections by such beneficiaries under subsection (a)(9) reflect personal preference; and ``(ii) submit the results of such audit to the Committee on Armed Services of the Senate and the Committee on Armed Services of the House of Representatives. ``(B) The Secretary shall ensure that, as a condition of any contract entered into for the administration of the pharmacy benefits program, the contractor provides the Comptroller General information required to conduct the audit under subparagraph (A).''. (c) Report.--Not later than 90 days after the date of the enactment of this Act, the Secretary of Defense shall submit to the congressional defense committees (as defined in section 101(a)(16) of title 10, United States Code) a plan for the implementation of this section. <all>\n--- KONIEC DOKUMENTU ---\n\nPAMIĘTAJ: Twoja odpowiedź MUSI być wyłącznie poprawnym obiektem JSON. Nie dodawaj żadnych dodatkowych znaków, komentarzy ani tekstu przed znacznikiem '{' ani po znaczniku '}'. Cała odpowiedź musi być parsowalna jako JSON.\nNa podstawie POWYŻSZEGO dokumentu, wypełnij poniższą strukturę JSON:\nOto struktura JSON, której oczekuję (wypełnij ją treścią):\n{\n  \"pl_ai_title\": \"Nowy, krótki tytuł dla aktu prawnego po polsku, oddający sedno wprowadzanych zmian (np. maksymalnie 10-12 słów).\",\n  \"pl_summary\": \"2-3 zdania zwięzłego podsumowania treści aktu prawnego po polsku, napisane z perspektywy wpływu na życie codzienne obywateli.\",\n  \"pl_key_points\": [\n    \"Pierwszy krótki punkt po polsku dotyczący najważniejszych wprowadzanych rozwiązań lub zmian.\",\n    \"Drugi krótki punkt po polsku...\"\n  ],\n  \"eng_ai_title\": \"A new, short title for the legal act in English, capturing the essence of the changes (e.g., max 10-12 words).\",\n  \"eng_summary\": \"2-3 sentences summarizing the legal act in English, from the perspective of its impact on citizens' daily lives.\",\n  \"eng_key_points\": [\n    \"First short bullet point in English regarding the most important solutions or changes being introduced.\",\n    \"Second short bullet point in English...\"\n  ],\n  \"de_ai_title\": \"Ein neuer, kurzer Titel für das Rechtsdokument auf Deutsch, der den Kern der Änderungen erfasst (z.B. max. 10-12 Wörter).\",\n  \"de_summary\": \"2-3 Sätze Zusammenfassung des Rechtsdokuments auf Deutsch, aus der Perspektive seiner Auswirkungen auf das tägliche Leben der Bürger.\",\n  \"de_key_points\": [\n    \"Erster kurzer Stichpunkt auf Deutsch zu den wichtigsten eingeführten Lösungen oder Änderungen.\",\n    \"Zweiter kurzer Stichpunkt auf Deutsch...\"\n  ],\n  \"fr_ai_title\": \"Un nouveau titre court pour l'acte juridique en français, saisissant l'essence des changements (par exemple, 10-12 mots maximum).\",\n  \"fr_summary\": \"Résumé de 2-3 phrases de l'acte juridique en français, du point de vue de son impact sur la vie quotidienne des citoyens.\",\n  \"fr_key_points\": [\n    \"Premier court point en français concernant les solutions ou changements les plus importants introduits.\",\n    \"Deuxième court point en français...\"\n  ],\n  \"es_ai_title\": \"Un nuevo título breve para el acto jurídico en español, que recoja la esencia de los cambios (por ejemplo, máximo 10-12 palabras).\",\n  \"es_summary\": \"Resumen de 2-3 frases del acto jurídico en español, desde la perspectiva de su impacto en la vida cotidiana de los ciudadanos.\",\n  \"es_key_points\": [\n    \"Primer punto breve en español sobre las soluciones o cambios más importantes que se introducen.\",\n    \"Segundo punto breve en español...\"\n  ],\n  \"it_ai_title\": \"Un nuovo titolo breve per l'atto giuridico in italiano, che colga l'essenza delle modifiche (ad es. massimo 10-12 parole).\",\n  \"it_summary\": \"Riepilogo di 2-3 frasi dell'atto giuridico in italiano, dal punto di vista del suo impatto sulla vita quotidiana dei cittadini.\",\n  \"it_key_points\": [\n    \"Primo breve punto in italiano riguardante le soluzioni o le modifiche più importanti introdotte.\",\n    \"Secondo breve punto in italiano...\"\n  ],\n  \"nl_ai_title\": \"Een nieuwe, korte titel voor de rechtshandeling in het Nederlands, die de essentie van de wijzigingen weergeeft (bijv. max. 10-12 woorden).\",\n  \"nl_summary\": \"Samenvatting van 2-3 zinnen van de rechtshandeling in het Nederlands, vanuit het perspectief van de impact op het dagelijks leven van burgers.\",\n  \"nl_key_points\": [\n    \"Eerste korte punt in het Nederlands betreffende de belangrijkste geïntroduceerde oplossingen of wijzigingen.\",\n    \"Tweede korte punt in het Nederlands...\"\n  ],\n  \"pt_ai_title\": \"Um novo título curto para o ato jurídico em português, capturando a essência das mudanças (por exemplo, máx. 10-12 palavras).\",\n  \"pt_summary\": \"Resumo de 2-3 frases do ato jurídico em português, na perspetiva do seu impacto na vida quotidiana dos cidadãos.\",\n  \"pt_key_points\": [\n    \"Primeiro ponto curto em português sobre as soluções ou alterações mais importantes introduzidas.\",\n    \"Segundo ponto curto em português...\"\n  ],\n  \"category\": [\"Categorize the document into one category by default, based on the field it primarily concerns. Choose up to 3 if the document also touches upon SIGNIFICANT issues from other categories. You MUST select categories ONLY from the following list: Health, Education, Family, Taxes, Labor, Security, Environment, Courts and Law, Transport, Benefits, Real Estate, Media and Culture, Local Government, Migration, Agriculture, Public Investments, Informatization, Economy. If the document does not definitively fit any of these, you MUST use \"Other\". If you use \"Other\", it should be the ONLY category selected. Do NOT invent new categories. The response must be an array of strings, e.g., [\"Taxes\", \"Family\"].\"]\n}\n\n",
      "ai_response_raw": "{\n  \"pl_ai_title\": \"Leki w programie TRICARE: większy wybór aptek i ochrona przed ukrytymi kosztami\",\n  \"pl_summary\": \"Ustawa daje osobom korzystającym z programu TRICARE większą swobodę w wyborze miejsca zakupu leków markowych. Wprowadza również zasady uczciwego opłacania lokalnych aptek, co ma zapobiec ich zamykaniu i poprawić dostęp do leków, zwłaszcza na wsiach.\",\n  \"pl_key_points\": [\n    \"Pacjenci mogą wybrać realizację recept na leki markowe w dowolnej aptece stacjonarnej zamiast tylko wysyłkowej.\",\n    \"Apteki otrzymają zwrot kosztów pokrywający realną cenę leku oraz standardową opłatę za jego wydanie.\",\n    \"Zakaz nakładania na apteki ukrytych, wstecznych lub dodatkowych opłat przez pośredników.\",\n    \"Coroczne kontrole dostępności aptek dla pacjentów, ze szczególnym uwzględnieniem obszarów wiejskich.\"\n  ],\n  \"eng_ai_title\": \"TRICARE Medications: Greater Pharmacy Choice and Protection from Hidden Costs\",\n  \"eng_summary\": \"This act gives TRICARE beneficiaries more freedom to choose where they purchase brand-name medications. It also establishes fair payment rules for local pharmacies to prevent closures and improve access to medicine, especially in rural areas.\",\n  \"eng_key_points\": [\n    \"Beneficiaries can choose to fill brand-name maintenance prescriptions at retail pharmacies instead of mail-order only.\",\n    \"Pharmacies must be reimbursed based on the actual cost of the drug plus a professional dispensing fee.\",\n    \"Middlemen are prohibited from charging pharmacies hidden, retroactive, or point-of-sale fees.\",\n    \"Mandatory annual audits will check if pharmacy networks are adequate and accessible in underserved areas.\"\n  ],\n  \"de_ai_title\": \"TRICARE-Medikamente: Mehr Apothekenwahl und Schutz vor versteckten Kosten\",\n  \"de_summary\": \"Dieses Gesetz gibt TRICARE-Versicherten mehr Freiheit bei der Wahl ihrer Apotheke für Markenmedikamente. Es führt faire Vergütungsregeln für lokale Apotheken ein, um deren Schließung zu verhindern und die Versorgung in ländlichen Gebieten zu sichern.\",\n  \"de_key_points\": [\n    \"Versicherte können Markenmedikamente in lokalen Apotheken statt nur per Versandhandel beziehen.\",\n    \"Apotheken erhalten eine Erstattung, die den tatsächlichen Einkaufspreis und eine feste Abgabengebühr abdeckt.\",\n    \"Verbot von versteckten oder nachträglichen Gebühren, die Zwischenhändler den Apotheken berechnen.\",\n    \"Jährliche Überprüfung der Erreichbarkeit von Apotheken, insbesondere in ländlichen und unterversorgten Regionen.\"\n  ],\n  \"fr_ai_title\": \"Médicaments TRICARE : plus de choix de pharmacies et protection contre les frais cachés\",\n  \"fr_summary\": \"Cette loi offre aux bénéficiaires de TRICARE une plus grande liberté pour choisir où acheter leurs médicaments de marque. Elle instaure des règles de paiement équitables pour les pharmacies locales afin d'améliorer l'accès aux soins, surtout en zone rurale.\",\n  \"fr_key_points\": [\n    \"Les patients peuvent choisir de retirer leurs médicaments de marque en pharmacie physique plutôt que par correspondance.\",\n    \"Les pharmacies seront remboursées sur la base du coût réel du médicament plus des frais de service standard.\",\n    \"Interdiction des frais cachés ou rétroactifs imposés aux pharmacies par les intermédiaires.\",\n    \"Audits annuels obligatoires pour garantir l'accessibilité des pharmacies dans les zones mal desservies.\"\n  ],\n  \"es_ai_title\": \"Medicamentos TRICARE: más opciones de farmacia y protección contra cargos ocultos\",\n  \"es_summary\": \"Esta ley otorga a los beneficiarios de TRICARE más libertad para elegir dónde comprar sus medicamentos de marca. Establece reglas de pago justo para las farmacias locales para evitar cierres y mejorar el acceso en zonas rurales.\",\n  \"es_key_points\": [\n    \"Los beneficiarios pueden elegir farmacias locales para sus medicamentos de marca en lugar de solo el envío por correo.\",\n    \"Las farmacias recibirán un reembolso que cubra el costo real del medicamento más una tarifa de despacho profesional.\",\n    \"Se prohíbe a los intermediarios imponer tarifas ocultas o retroactivas a las farmacias.\",\n    \"Auditorías anuales para verificar que el acceso a las farmacias sea suficiente en áreas rurales y desatendidas.\"\n  ],\n  \"it_ai_title\": \"Farmaci TRICARE: più scelta della farmacia e stop ai costi nascosti\",\n  \"it_summary\": \"Questa legge offre ai beneficiari TRICARE maggiore libertà nella scelta di dove acquistare i farmaci di marca. Introduce regole per rimborsi equi alle farmacie locali, proteggendo l'accesso ai medicinali soprattutto nelle zone rurali.\",\n  \"it_key_points\": [\n    \"I pazienti possono scegliere la farmacia fisica per i farmaci di marca invece dell'obbligo di spedizione a domicilio.\",\n    \"Le farmacie devono essere rimborsate in base al costo effettivo del farmaco più una tariffa professionale.\",\n    \"Divieto di commissioni nascoste o retroattive applicate dagli intermediari alle farmacie.\",\n    \"Controlli annuali sulla rete delle farmacie per garantire la copertura nelle zone meno servite.\"\n  ],\n  \"nl_ai_title\": \"TRICARE-medicijnen: meer apotheekkeuze en bescherming tegen verborgen kosten\",\n  \"nl_summary\": \"Deze wet geeft TRICARE-verzekerden meer vrijheid om te kiezen waar ze hun merkgeneesmiddelen kopen. Het voert eerlijke betalingsregels in voor lokale apotheken om de toegang tot zorg in landelijke gebieden te waarborgen.\",\n  \"nl_key_points\": [\n    \"Patiënten kunnen kiezen voor een lokale apotheek voor merkgeneesmiddelen in plaats van alleen postorder.\",\n    \"Apotheken krijgen een vergoeding die de werkelijke inkoopkosten en een standaard verwerkingsfee dekt.\",\n    \"Verbod op verborgen of achteraf berekende kosten die tussenpersonen aan apotheken opleggen.\",\n    \"Jaarlijkse controles op de bereikbaarheid van apotheken, met extra aandacht voor achtergestelde gebieden.\"\n  ],\n  \"pt_ai_title\": \"Medicamentos TRICARE: mais escolha de farmácia e proteção contra taxas ocultas\",\n  \"pt_summary\": \"Esta lei dá aos beneficiários do TRICARE mais liberdade para escolher onde comprar os seus medicamentos de marca. Estabelece regras de pagamento justo para as farmácias locais, melhorando o acesso à saúde em zonas rurais.\",\n  \"pt_key_points\": [\n    \"Os utentes podem optar por levantar medicamentos de marca em farmácias locais em vez de apenas por correio.\",\n    \"As farmácias devem ser reembolsadas pelo custo real do medicamento mais uma taxa de serviço profissional.\",\n    \"Proibição de taxas ocultas ou retroactivas aplicadas por intermediários às farmácias.\",\n    \"Auditorias anuais obrigatórias para garantir que as farmácias são acessíveis em áreas carenciadas.\"\n  ],\n  \"category\": [\"Health\", \"Benefits\", \"Security\"]\n}"
    }
  ]
}